Scott Glaser

Scott Glaser, M.D.

  • Assistant Clinical Professor, Department of Radiation Oncology
  • Radiation Oncologist

Scott Glaser, M.D.

Clinical Specialties
  • Radiation Oncology
Areas of Expertise
  • High-dose Rate Brachytherapy
  • Stereotactic Radiosurgery
  • Intensity Modulated Radiation Therapy
  • Gynecological Cancer
  • Breast Cancer
  • Prostate Cancer
Scott Glaser, M.D., is an assistant clinical professor of radiation oncology at City of Hope.  He specializes in high-dose rate brachytherapy, stereotactic radiosurgery and intensity modulated radiation therapy.  His particular areas of interest include gynecological, breast and prostate cancers.

Dr. Glaser received an undergraduate degree from Hope College in Holland, Michigan, and a medical degree from the Loyola University Stritch School of Medicine in Chicago. He completed a medical internship at the University of Nevada, Reno, followed by a residency in radiation oncology at the University of Pittsburgh.

Dr. Glaser is a member of numerous professional organizations, including American Society for Radiation Oncology, American College of Radiation Oncology and the American Brachytherapy Society. He has published over 20 manuscripts in peer-reviewed medical journals, and serves as a reviewer for multiple scientific journals.
  • 2017-present, Assistant Clinical Professor, Department of Radiation Oncology


City of Hope Comprehensive Cancer Center, 1500 East Duarte Road, Duarte, CA, 91010

Get Directions

Phone :  626-256-4673


  • 2012, M.D., with "Honors in Research", Loyola University Chicago, Stritch School of Medicine
  • 2008, B.S., Chemistry, B.A., Psychology, Summa Cum Laude, Hope College (Holland MI)


  • 2013-2017, Radiation Oncology, University of Pittsburgh Medical Center


  • 2012-2013, Internal Medicine, University of Nevada, Reno
  • Glaser S, Mahantshetty U, Lee L, Klopp A, Beriwal S. Genomics and 3-Dimensional Brachytherapy for Cervical Cancer: Significant Steps Forward. Int J Radiat Biol Phys. 2017;99:505-509.
  • Gebhardt B, Gill B, Glaser S, Kim H, Houser C, Kelley J, Sukumvanich P, Edwards R, Comerci J, Olawaiye A, Courtney-Brooks M, Boisen M, Berger J, Beriwal S. Image-guided tandem and cylinder brachytherapy as monotherapy for definitive treatment of inoperable endometrial carcinoma. Gynecol Oncol. 2017 in press
  • Champ C, Ohri N, Klement R, Cantor M, Beriwal S, Glaser S, Smith R. Assessing Changes in the Activity Levels of Breast Cancer Patients during Radiation Therapy. Clin Breast Cancer. 2017 in press
  • Dohopolski M, Glaser S, Vargo J, Balasubramani G, Beriwal S. Stereotactic body radiotherapy for locally-advanced unresectable pancreatic cancer – patterns of care and overall survival. J Gastrointest Oncol. 2017;8(5):766-777.
  • Chen K, Glaser S, Kim H, Beriwal S. Differences in Urethral Dosimetry between CT and MR Imaging in Multichannel Vaginal Cylinder Brachytherapy. Brachytherapy. 2017;16:964-967.
  • Glaser S, Dohopolski M, Balasubramani G, Flickinger J, Beriwal S. Glioblastoma Multiforme (GBM) in the Elderly: Initial Treatment Strategy and Overall Survival. J Neurooncol. 2017;134:107-118.
  • Gogineni E, Vargo J, Glaser S, Flickinger J, Burton S, Engh J, Amankulor N, Beriwal S, Quinn A, Ozhasoglu C, Heron D. Long-term survivorship following stereotactic radiosurgery alone for brain metastases: risk of intracranial failure and implications for surveillance and counseling. Neurosurgery. 2017 epub ahead of print
  • Glaser S, Chen K, Benoit R, Smith R, Beriwal S. Long-term Quality of Life in Prostate Cancer Patients Treated with Cesium-131. Int J Radiat Oncol Biol Phys. 2017;98:1053-1058.
  • Vargo J, Patel A, Glaser S, Balasubramani G, Farah R, Marks S, Beriwal S. The Impact of the Omission or Inadequate Dosing of Radiotherapy in Extranodal Natural Killer T-cell Lymphoma, Nasal Type, in the United States. Cancer. 2017;123:3176-3185.
  • Glaser S, Dohopolski M, Balasubramani G, Benoit R, Smith R, Beriwal S. Brachytherapy Boost for Prostate Cancer: Trends in Care and Survival Outcomes. Brachytherapy. 2017;16:330-341.
  • Bernard M, Glaser S, Gill B, Beriwal S, Heron D, Luketich J, Firedland D, Socinski M, Greenberger J. Results of a Single Institution Experience with Dose Escalated Chemoradiation for Locally-Advanced Unresectable Non-Small Cell Lung Cancer. Front Oncol. 2017;7:1.
  • Horne Z, Glaser S, Vargo J, Ferris R, Balasubramani G, Clump D, Heron D, Beriwal S. Validation of proposed HPV risk-adapted staging according to AJCC/UICC TNM criteria for positive oropharyngeal carcinomas. Cancer. 2016;122(13):2021-2030.
  • Glaser S, Vargo J, Balasubramani G, Beriwal S. Stage II testicular seminoma: Patterns of care and survival by treatment strategy. Clinical Oncology. 2016;28(8):513-521.
  • Glaser S, Mandish S, Gill B, Balasubramani G, Clump D, Beriwal S. Anaplastic Thyroid Cancer - Prognostic Factors, Patterns of Care, and Overall Survival. Head and Neck. 2016;38(S1):E2083-2090.
  • Glaser S, Vargo J, Balasubramani G, Beriwal S. Surveillance and Radiotherapy for Stage I Seminoma Have We Learned From the Evidence? Int J Radiat Oncol Biol Phys. 2016;94(1):75-84.
  • Glaser S, Beriwal S. Brachytherapy for malignancies of the vagina in the 3D era. J Contemp Brachytherapy. 2015;7:312-318.
  • Glaser S, Kim H, Beriwal S. Multi-Channel Vaginal Cylinder Brachytherapy: Impact of Tumor Size and Location on Dose to Organs at Risk. Brachytherapy. 2015;14(6):913-918.
  • Glaser S, Olawaiye A, Huang M, Beriwal S. Inguinal Nodal Region Radiotherapy for Vulvar Cancer: Are We Missing the Target Again? Gynecol Oncol. 2014;135(3):583-585.
  • Glaser S, Warfel B, Price J, Sinacor J, Albuquerque K. Effectiveness of Virtual Reality Simulation Software in Radiotherapy Treatment Planning Involving Non-Coplanar Beams with Partial Breast Irradiation as a Model. Technol Cancer Res Treat. 2012;11:409-414.
  • Soto D, Glaser S, Roberts R, Schipper M, McLaughlin P, Ray M, Sandler H, Pan C. Impact of Common Iliac Nodal Treatment on Radiation Outcomes in Localized Prostate Cancer.  Urology 2008;71:313-317.
  • The Radiosurgery Society (RSS)
  • American Society of Therapeutic Radiology and Oncology (ASTRO)
  • American Brachytherapy Society (ABS)
  • American College of Radiation Oncology (ACRO)
  • European Society for Therapeutic Radiology and Oncology (ESTRO)
Back To Top